Why in news?
The Department of Pharmaceuticals (DoP) has ruled in favour of drug companies, prohibiting the National Pharmaceutical Pricing Authority (NPPA) from reducing prices of medicines that are selling below the capped prices.
Why there is tussle between NPPA and DoP?
What IPA says?
What NPPA has contended?
What DoP has contended?
Category: Mains| GS-II| Government Intervention
Source: Business Line